Barrington raised the firm’s price target on Barrett Business (BBSI) to $45 from $41 and keeps an Outperform rating on the shares following the Q3 earnings beat. The firm expects the company’s revenue growth rates to improve in 2024 and 2025 on improved demand and strong health benefits product prospects.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter